Literature DB >> 17848298

Hypoxia in head and neck cancer: studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins.

Danny Rischin1, Richard Fisher, Lester Peters, June Corry, Rodney Hicks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17848298     DOI： 10.1016/j.ijrobp.2007.05.043

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  12 in total

1.  Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins.

Authors:  Michael P Hay; Kevin O Hicks; Karin Pchalek; Ho H Lee; Adrian Blaser; Frederik B Pruijn; Robert F Anderson; Sujata S Shinde; William R Wilson; William A Denny
Journal:  J Med Chem       Date:  2008-10-11       Impact factor: 7.446

2.  Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced head and neck cancer.

Authors:  Quynh-Thu Le; Richard Fisher; Kelly S Oliner; Richard J Young; Hongbin Cao; Christina Kong; Edward Graves; Rodney J Hicks; Grant A McArthur; Lester Peters; Brian O'Sullivan; Amato Giaccia; Danny Rischin
Journal:  Clin Cancer Res       Date:  2012-03-01       Impact factor: 12.531

Review 3.  Biology of human papillomavirus-related oropharyngeal cancer.

Authors:  Jason D Howard; Christine H Chung
Journal:  Semin Radiat Oncol       Date:  2012-07       Impact factor: 5.934

4.  Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.

Authors:  Danny Rischin; Richard J Young; Richard Fisher; Stephen B Fox; Quynh-Thu Le; Lester J Peters; Ben Solomon; Jimin Choi; Brian O'Sullivan; Lizbeth M Kenny; Grant A McArthur
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

5.  Quantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome.

Authors:  Edward E Graves; Rodney J Hicks; David Binns; Mathias Bressel; Quynh-Thu Le; Lester Peters; Richard J Young; Danny Rischin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-18       Impact factor: 9.236

6.  A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy.

Authors:  Stéphanie Servagi-Vernat; Sarah Differding; Francois-Xavier Hanin; Daniel Labar; Anne Bol; John A Lee; Vincent Grégoire
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-26       Impact factor: 9.236

7.  Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy.

Authors:  Nancy Lee; Sadek Nehmeh; Heiko Schöder; Matthew Fury; Kelvin Chan; C Clifton Ling; John Humm
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-02-07       Impact factor: 7.038

Review 8.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities.

Authors:  Joseph C Walsh; Artem Lebedev; Edward Aten; Kathleen Madsen; Liane Marciano; Hartmuth C Kolb
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

Review 9.  The role of PET-CT in the management of patients with advanced cancer of the head and neck.

Authors:  June Corry; Danny Rischin; Rodney J Hicks; Lester J Peters
Journal:  Curr Oncol Rep       Date:  2008-03       Impact factor: 5.075

Review 10.  Therapeutic targeting of the hypoxic tumour microenvironment.

Authors:  Dean C Singleton; Andrew Macann; William R Wilson
Journal:  Nat Rev Clin Oncol       Date:  2021-07-29       Impact factor: 66.675
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.